A message to all our Healthcare Partners, patients, and wider communities (COVID-19)

As part of STADA’s global mission of ‘Caring for People’s Health’, Britannia Pharmaceuticals Ltd is committed to putting people at the heart of everything we do.

Following the latest Government announcement for return to work and living with Covid 19. We recognise this is going to be an ever-evolving health situation therefore we will continue to take steps as an organisation to play our part in supporting both patients and our employees.

Working closely with our supply-chain partners and relevant authorities, Britannia is taking several measures to safeguard access to medication for patients and healthcare professionals in relation to latest UK guidance and legislation.

Whilst still supporting healthcare systems, which is still a key priority for Britannia in learning to live with Covid 19, so too is protecting the health and well-being of our employees. Our offices are open, and as staff return, we will continue to monitor and keep in place additional measures to help mitigate the spread of the virus and to ensure the safety of our employees.

We are committed to our Duty of Care for both patients and our employees.

We would also like to thank all of our colleagues across the STADA group for their collaboration and commitment in the spirit of One STADA.

COVID-19 Risk Assessment

Please download our risk assessment PDF for information on our COVID-19 procedures.